Ab&B Bio-Tech Co. Ltd. JS

Status: Publicly traded

Direct answer

Ab&B Bio-Tech Co. Ltd. JS is publicly traded on HKSE under the ticker 2627.HK.

Ab&B Bio-Tech Co., Ltd. engages in the research, development, manufacturing and commercialization of innovative and traditional vaccines. Its products include quadrivalent subunit influenza and lyophilized human rabies vaccines. The company was founded by You Cai An on October 28, 2015 and is headquartered in Taizhou, China.

Can you invest in Ab&B Bio-Tech Co. Ltd. JS?

Yes. Ab&B Bio-Tech Co. Ltd. JS is publicly traded on HKSE under the ticker 2627.HK.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Ab&B Bio-Tech Co. Ltd. JS

Detailed equity research is provided by MarketSnap.